NO20022468D0 - Genterapi av HIV-positive pasienter ved ekspresjon av membranforankrede GP41-peptider - Google Patents

Genterapi av HIV-positive pasienter ved ekspresjon av membranforankrede GP41-peptider

Info

Publication number
NO20022468D0
NO20022468D0 NO20022468A NO20022468A NO20022468D0 NO 20022468 D0 NO20022468 D0 NO 20022468D0 NO 20022468 A NO20022468 A NO 20022468A NO 20022468 A NO20022468 A NO 20022468A NO 20022468 D0 NO20022468 D0 NO 20022468D0
Authority
NO
Norway
Prior art keywords
membrane
hiv
anchored
peptides
expression
Prior art date
Application number
NO20022468A
Other languages
English (en)
Other versions
NO20022468L (no
Inventor
Meike-Dorothee Von Laer
Original Assignee
Pette Heinrich Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pette Heinrich Inst filed Critical Pette Heinrich Inst
Publication of NO20022468D0 publication Critical patent/NO20022468D0/no
Publication of NO20022468L publication Critical patent/NO20022468L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20022468A 1999-11-25 2002-05-24 Genterapi av HIV-positive pasienter ved ekspresjon av membranforankrede GP41-peptider NO20022468L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19957838A DE19957838C2 (de) 1999-11-25 1999-11-25 Gentherapie von HIV-Infizierten durch Expression von Membran-verankerten gp41-Peptiden
PCT/EP2000/011733 WO2001037881A2 (de) 1999-11-25 2000-11-24 Gentherapie von hiv-infizierten durch expression von membran-verankerten gp41-peptiden

Publications (2)

Publication Number Publication Date
NO20022468D0 true NO20022468D0 (no) 2002-05-24
NO20022468L NO20022468L (no) 2002-07-22

Family

ID=7931006

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022468A NO20022468L (no) 1999-11-25 2002-05-24 Genterapi av HIV-positive pasienter ved ekspresjon av membranforankrede GP41-peptider

Country Status (21)

Country Link
US (1) US7790870B1 (no)
EP (1) EP1234044B1 (no)
JP (1) JP2003529339A (no)
KR (1) KR100840430B1 (no)
CN (1) CN1425072A (no)
AT (1) ATE412757T1 (no)
AU (1) AU3004101A (no)
BR (1) BR0015942A (no)
CA (1) CA2392468A1 (no)
CZ (1) CZ20021764A3 (no)
DE (2) DE19957838C2 (no)
EA (1) EA006434B1 (no)
ES (1) ES2315247T3 (no)
HK (1) HK1049186B (no)
HU (1) HUP0203518A2 (no)
NO (1) NO20022468L (no)
PL (1) PL358785A1 (no)
SK (1) SK7132002A3 (no)
UA (1) UA78968C2 (no)
WO (1) WO2001037881A2 (no)
ZA (1) ZA200204710B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10257770A1 (de) * 2002-12-10 2004-07-08 Ruprecht-Karls-Universität Heidelberg Expression von Peptiden des zytoplasmatischen Bereiches von HIV-gp41 zur Hemmung viraler Infektionen
CA2548483A1 (en) * 2003-08-26 2005-03-10 Uwe Fiebig Induction of antiviral neutralizing antibodies in humans and animals
WO2005056804A1 (ja) * 2003-12-11 2005-06-23 Takara Bio Inc. レセプターの機能の調節方法
GB0422439D0 (en) * 2004-10-08 2004-11-10 European Molecular Biology Lab Embl Inhibitors of infection
AU2006207181A1 (en) * 2005-01-24 2006-07-27 Yeda Research & Development Co. Ltd. HIV-1 gp41 fusion peptides for immunomodulation
EP4397748A1 (en) * 2021-08-30 2024-07-10 Kanglin Biotechnology (Hangzhou) Co., Ltd. Gene sequence construct for gene therapy for hiv infection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935233A (en) * 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US5851828A (en) * 1991-03-07 1998-12-22 The General Hospital Corporation Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
US5858744A (en) * 1994-09-08 1999-01-12 Boehringer Mannheim Gmbh Retroviral vector hybrids and the use thereof for gene transfer
EP0817854A2 (en) * 1995-03-31 1998-01-14 Wolf, Hans, Prof. Dr. Antigen presentation system based on retrovirus-like particles
FR2762851B1 (fr) * 1997-04-30 1999-10-29 Inst Nat Sante Rech Med Construction et expression d'enveloppe chimerique de retrovirus par des vecteurs et compositions pharmaceutiques les contenant
AU3220500A (en) * 1999-02-02 2000-08-25 Uab Research Foundation, The Hiv drug resistance system

Also Published As

Publication number Publication date
AU3004101A (en) 2001-06-04
WO2001037881A2 (de) 2001-05-31
HK1049186A1 (en) 2003-05-02
KR100840430B1 (ko) 2008-06-20
EA200200598A1 (ru) 2002-12-26
WO2001037881A9 (de) 2002-11-07
EP1234044A2 (de) 2002-08-28
SK7132002A3 (en) 2002-10-08
HK1049186B (zh) 2009-02-27
KR20020060752A (ko) 2002-07-18
WO2001037881A3 (de) 2001-12-13
EA006434B1 (ru) 2005-12-29
CN1425072A (zh) 2003-06-18
JP2003529339A (ja) 2003-10-07
HUP0203518A2 (en) 2003-02-28
BR0015942A (pt) 2002-08-27
DE50015431D1 (de) 2008-12-11
PL358785A1 (en) 2004-08-23
NO20022468L (no) 2002-07-22
CZ20021764A3 (cs) 2003-02-12
ATE412757T1 (de) 2008-11-15
US7790870B1 (en) 2010-09-07
ZA200204710B (en) 2003-05-15
DE19957838C2 (de) 2002-11-21
DE19957838A1 (de) 2001-06-13
ES2315247T3 (es) 2009-04-01
CA2392468A1 (en) 2001-05-31
EP1234044B1 (de) 2008-10-29
UA78968C2 (en) 2007-05-10

Similar Documents

Publication Publication Date Title
DE69326069D1 (de) Zusammensetzungen die die hiv replikation inhibieren
DK1278534T3 (da) Fremgangsmåder og sammensætninger til svækkelse af multiplikationen af HIV-1
DK1171465T3 (da) Analoger til gastroinhibitorisk peptid og deres anvendelse til behandling af diabetes
WO2007149491A3 (en) Soluble stabilized trimeric hiv env proteins and uses thereof
NZ521396A (en) Fusion proteins comprising two or more Neisseria polypeptides
ATE380822T1 (de) Funf-helix protein
DK1349944T3 (da) Latensassocieret peptid af TGF-beta til at bibringe farmaceutisk aktive proteiner latens
NO20022468D0 (no) Genterapi av HIV-positive pasienter ved ekspresjon av membranforankrede GP41-peptider
DE60044754D1 (de) Trans-lentivirales Vektor System
BR9710975A (pt) Genes de proteìna de adesão de superfìcie exposta de 120 kda imunodominante de ehrlichia chaffeensis
DE60236579D1 (de) Bakteriophagenvermittelte impfung
GB2368846B (en) Isolated Jaagsiekte retroviruses (JSRV), gene delivery vectors, and methods of use
ATE296314T1 (de) Peptide des env-gens vom katze immunschwäche- virus und deren verwendung
WO2003029285A3 (en) Identification of cd8 epitopes from hiv-1 proteins for prevention and therapy of hiv infections
NZ513549A (en) Malaria vaccine
WO2006078268A3 (en) A peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5
GB2336844A (en) Anti-hiv peptides and proteins
WO2003104262A3 (en) GP41 PEPTIDES AND METHODS USING SUCH PEPTIDES TO INHIBIT HIV FUSION WITH TARGET CELLS
DK1545594T3 (da) Bakteriofag-medieret immunisering mod Hepatitis
SE9600436D0 (sv) Vaccine against hantavirus
SE9703287D0 (sv) Peptides
WO2000053789A3 (de) Retrovirale expressionsvektoren auf der basis von herv-ltr-sequenzen
TH31634A (th) เพพไทด์ชนิดใหม่ที่เหมาะสมสำหรับใช้ในการบำบัดรักษาที่กดภูมิคุ้มกันที่มีความจำเพาะต่อแอนติเจน
WO2002068464A3 (de) Fusionsprotein zum blocken des hiv nef-proteins
TH13136EX (th) แอนติเจนของ hiv

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application